Wealth Enhancement Advisory Services LLC Has $607,000 Stake in The Cooper Companies, Inc. $COO

Wealth Enhancement Advisory Services LLC lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,276 shares of the medical device company’s stock after selling 348 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Cooper Companies were worth $607,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in COO. Impact Capital Partners LLC increased its position in shares of Cooper Companies by 4.4% during the first quarter. Impact Capital Partners LLC now owns 8,416 shares of the medical device company’s stock worth $710,000 after acquiring an additional 352 shares in the last quarter. UMB Bank n.a. grew its position in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company’s stock worth $76,000 after purchasing an additional 129 shares in the last quarter. Baldwin Wealth Partners LLC MA grew its position in shares of Cooper Companies by 44.7% during the 1st quarter. Baldwin Wealth Partners LLC MA now owns 164,581 shares of the medical device company’s stock valued at $13,882,000 after acquiring an additional 50,862 shares during the period. City Holding Co. bought a new position in shares of Cooper Companies during the 1st quarter valued at approximately $34,000. Finally, SG Americas Securities LLC lifted its stake in shares of Cooper Companies by 8,337.0% during the 1st quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company’s stock valued at $31,171,000 after buying an additional 365,162 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.9%

Shares of NASDAQ COO opened at $70.46 on Friday. The firm’s 50 day moving average price is $69.69 and its 200-day moving average price is $74.12. The company has a market cap of $14.01 billion, a PE ratio of 34.71, a P/E/G ratio of 1.85 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $109.37. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies announced that its Board of Directors has initiated a share buyback program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. UBS Group upgraded shares of Cooper Companies to a “buy” rating in a research note on Tuesday, June 17th. The Goldman Sachs Group set a $64.00 price target on shares of Cooper Companies and gave the stock a “sell” rating in a research note on Wednesday. BNP Paribas Exane upgraded shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price objective on the stock in a research report on Tuesday, July 22nd. BNP Paribas upgraded shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 22nd. Finally, Loop Capital set a $100.00 price target on shares of Cooper Companies in a research report on Tuesday, June 17th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $84.75.

Insider Activity at Cooper Companies

In other Cooper Companies news, EVP Brian G. Andrews bought 1,525 shares of Cooper Companies stock in a transaction on Tuesday, September 2nd. The stock was acquired at an average cost of $65.68 per share, with a total value of $100,162.00. Following the completion of the acquisition, the executive vice president owned 22,191 shares in the company, valued at approximately $1,457,504.88. This represents a 7.38% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Gerard H. Warner III bought 1,450 shares of Cooper Companies stock in a transaction on Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the acquisition, the chief operating officer owned 18,319 shares of the company’s stock, valued at $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 17,975 shares of company stock valued at $1,216,346 over the last quarter. 1.98% of the stock is owned by company insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.